Chargement en cours...

PF-06438179/GP1111: An Infliximab Biosimilar

PF-06438179/GP1111 (Zessly(®); Ixifi(®)) [hereafter referred to as GP1111] is a biosimilar of the reference monoclonal anti-TNF-α antibody infliximab, and is approved in the EU and USA for the same indications as the reference drug, including rheumatoid arthritis (RA), Crohn’s disease, ulcerative co...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BioDrugs
Auteur principal: Al-Salama, Zaina T.
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6290860/
https://ncbi.nlm.nih.gov/pubmed/30284704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-018-0310-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!